Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


03.09.2018

1 Antimicrob Agents Chemother
1 J Immunol
3 J Virol
2 Lancet Child Adolesc Health
2 PLoS One
1 Proc Natl Acad Sci U S A
3 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. ALI SO, Takas T, Nyborg A, Shoemaker K, et al
    Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00694.
    PubMed     Text format     Abstract available


    J Immunol

  2. MALTBY S, Lochrin AJ, Bartlett B, Tay HL, et al
    Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice.
    J Immunol. 2018;200:632-642.
    PubMed     Text format     Abstract available


    J Virol

  3. PULIT-PENALOZA JA, Pappas C, Belser JA, Sun X, et al
    Comparative in vitro and in vivo analysis of H1N1 and H1N2 variant influenza viruses isolated from humans between 2011 and 2016.
    J Virol. 2018 Aug 29. pii: JVI.01444-18. doi: 10.1128/JVI.01444.
    PubMed     Text format     Abstract available

  4. WOHLGEMUTH N, Lane AP, Pekosz A
    Influenza A virus M2 protein apical targeting is required for efficient virus replication.
    J Virol. 2018 Aug 29. pii: JVI.01425-18. doi: 10.1128/JVI.01425.
    PubMed     Text format     Abstract available

  5. WESSELS U, Abdelwhab EM, Veits J, Hoffmann D, et al
    A Dual Motif in the Hemagglutinin of H5N1 Goose/Guangdong-Like Highly Pathogenic Avian Influenza Virus Strains Is Conserved from Their Early Evolution and Increases both Membrane Fusion pH and Virulence.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    Lancet Child Adolesc Health

  6. CLAEYS C, Zaman K, Dbaibo G, Li P, et al
    Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.
    Lancet Child Adolesc Health. 2018;2:338-349.
    PubMed     Text format     Abstract available

  7. COWLING BJ, Chiu SS
    Efficacy of inactivated influenza vaccines in young children.
    Lancet Child Adolesc Health. 2018;2:307-308.
    PubMed     Text format    


    PLoS One

  8. CHENG X, Chen T, Yang Y, Yang J, et al
    Using an innovative method to develop the threshold of seasonal influenza epidemic in China.
    PLoS One. 2018;13:e0202880.
    PubMed     Text format     Abstract available

  9. RULE AM, Apau O, Ahrenholz SH, Brueck SE, et al
    Healthcare personnel exposure in an emergency department during influenza season.
    PLoS One. 2018;13:e0203223.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  10. MADSEN JJ, Grime JMA, Rossman JS, Voth GA, et al
    Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1805443115.
    PubMed     Text format     Abstract available


    Vaccine

  11. STONE K, Akpalu Y, Horney J
    Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31139.
    PubMed     Text format     Abstract available

  12. NEWALL AT, Chen C, Wood JG, Stockwell MS, et al
    Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31114.
    PubMed     Text format     Abstract available

  13. WHITAKER JA, von Itzstein MS, Poland GA
    Strategies to maximize influenza vaccine impact in older adults.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31169.
    PubMed     Text format     Abstract available


    Virology

  14. OHTA K, Matsumoto Y, Yumine N, Nishio M, et al
    The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
    Virology. 2018;524:90-96.
    PubMed     Text format     Abstract available

  15. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
    Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
    Virology. 2018;524:69-77.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: